HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$10.59
Day range
$10.56 - $12.71
Year range
$5.68 - $13.60
Market cap
734.91M USD
Avg Volume
1.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.60M | 13.80% |
Net income | -50.61M | -24.78% |
Net profit margin | — | — |
Earnings per share | -0.77 | -11.59% |
EBITDA | -55.52M | -13.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 332.60M | -42.47% |
Total assets | 484.13M | -25.89% |
Total liabilities | 32.76M | 29.01% |
Total equity | 451.37M | — |
Shares outstanding | 59.08M | — |
Price to book | 1.39 | — |
Return on assets | -27.67% | — |
Return on capital | -29.38% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -50.61M | -24.78% |
Cash from operations | -36.88M | -8.02% |
Cash from investing | 67.39M | 239.03% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 30.52M | 335.89% |
Free cash flow | -19.54M | -2.86% |
About
Founded
2016
Website
Employees
111
